Table 1 Characteristics of participants
From: A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
Characteristics | All | Part I | Part II |
|---|---|---|---|
Participants; n | 36 | 12 | 24 |
Age; years | |||
Median | 59.5 | 38.0 | 62.0 |
Range | 23–70 | 23–50 | 56–70 |
Mean (s.d.) | 54.8 (12.9) | 38.7 (8.2) | 62.8 (4.1) |
Sex; n (%) | |||
Female | 16 (44) | 4 (33) | 12 (50) |
Male | 20 (56) | 8 (67) | 12 (50) |
Ethnicity; n (%) | |||
White | 36 (100) | 12 (100) | 24 (100) |
Other | 0 (0) | 0 (0) | 0 (0) |
Body mass indexa | |||
Median | 24.4 | 24.9 | 24.4 |
Range | 18.5–30.1 | 20.1–30.1 | 18.5–29.3 |
Relevant pre-existing diseaseb; n (%) | |||
Hypertension | 6 (16.7) | 0 (0) | 6 (25) |
Previous malignant disease | 1 (2.8) | 0 (0) | 1 (4.2) |
Mild psoriasis | 1 (2.8) | 0 (0) | 1 (4.2) |
